Novel microRNA-based Assay Demonstrates 92% Agreement With Diagnosis Based on Clinicopathologic and Management Data in a Cohort of Patients With Carcinoma of Unknown Primary

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-12-57
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Role of 92 Gene Cancer Classifier Assay in Neuroendocrine Tumor of Unknown Primary

Journal of the American College of Surgeons
Surgery
2017English

Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients With the Unknown Primary Site

Cureus
2019English

Prognostic Clinicopathologic Factors in Carcinoma of Unknown Primary Origin: A Study of 106 Consecutive Cases

Oncotarget
Oncology
2017English

Clinicopathologic Characteristics and Prognosis of Patients With Adrenocortical Carcinoma

Japanese Journal of Urology
Urology
2014English

Detection of Epstein-Barr Virus in Metastatic Lymph Nodes of Patients With Nasopharyngeal Carcinoma and a Primary Unknown Carcinoma

Archives of Otolaryngology–Head & Neck Surgery
2003English

Cancer Risk in Chinese Diabetes Patients: A Retrospective Cohort Study Based on Management Data

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Population-Based Analysis of Patients With COPD in Catalonia: A Cohort Study With Implications for Clinical Management

BMJ Open
Medicine
2018English

Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown Primary

Asian Pacific Journal of Cancer Prevention
2019English

Survival of Patients With Chronic Myeloproliferative Neoplasms and New Primary Cancers: A Population-Based Cohort Study

The Lancet Haematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy